+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pneumococcal Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5483532
  • Report
  • November 2021
  • Region: Global
  • 145 Pages
  • IMARC Group

FEATURED COMPANIES

  • Astellas Pharma Inc.
  • GlaxoSmithKline Plc.
  • Merck & Co. Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
The global pneumococcal vaccine market grew at a CAGR of around 5% during 2015 & 2020. Pneumococcal disease is caused by Streptococcus pneumoniae bacterium that can lead to severe infection of the lungs (pneumonia) and blood (bacteremia) or the lining of the brain and spinal cord (meningitis). The vaccines help protect both children and adults by stimulating the immune system and protecting against the bacterial strains responsible for severe infections. As these vaccines help prevent infection from spreading, reduce fatality rate and eliminate the need for hospitalization, they are widely being used across the globe.

According to the World Health Organization (WHO), children under 2-5 years of age are at a high risk of developing pneumococcal disease. This, in confluence with the escalating number of birth rates and the growing concerns among parents about the health of their children, represents one of the major factors bolstering the market growth. Additionally, the increasing geriatric population is contributing to the market growth. This can also be accredited to the contagiousness of the disease, which can cause severe complications in older adults. Furthermore, the rising number of smokers and individuals living with chronic health conditions is positively influencing the market growth. Moreover, the introduction of the Pneumococcal Conjugate Vaccine (PCV) in infant routine immunization by governing agencies of numerous countries is anticipated to propel the market growth. Apart from this, the growing cases of the coronavirus disease (COVID-19) have promoted the utilization of pneumococcal vaccines as a preventative measure against the increased risk of lung infections caused by the viral disease. Looking forward, the publisher expects the global pneumococcal vaccine market to exhibit moderate growth during the next five years.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global pneumococcal vaccine market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, vaccine type, product type, distribution channel and end user.

Breakup by Vaccine Type:

  • Pneumococcal Conjugate Vaccine
  • Pneumococcal Polysaccharide Vaccine

Breakup by Product Type:

  • Prevnar 13
  • Synflorix
  • Pneumovax 23

Breakup by Distribution Channel:

  • Distribution Partner Companies
  • Non-Governmental Organizations (NGO)
  • Government Authorities

Breakup by End User:

  • Pediatrics
  • Adults

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., GlaxoSmithKline Plc., Merck & Co. Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt Ltd and Walvax Biotechnology Co. Ltd.

Key Questions Answered in This Report:

  • How has the global pneumococcal vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pneumococcal vaccine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pneumococcal vaccine market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Astellas Pharma Inc.
  • GlaxoSmithKline Plc.
  • Merck & Co. Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi S.A.

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pneumococcal Vaccine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Vaccine Type
6.1 Pneumococcal Conjugate Vaccine
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Pneumococcal Polysaccharide Vaccine
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product Type
7.1 Prevnar 13
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Synflorix
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Pneumovax 23
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Distribution Partner Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Non-Governmental Organizations (NGO)
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Government Authorities
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End User
9.1 Pediatrics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Adults
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Astellas Pharma Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 GlaxoSmithKline Plc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Merck & Co. Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Panacea Biotec Ltd.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Pfizer Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Sanofi S.A.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Serum Institute of India Pvt Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Walvax Biotechnology Co. Ltd.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
List of Figures
Figure 1: Global: Pneumococcal Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Pneumococcal Vaccine Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Pneumococcal Vaccine Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Pneumococcal Vaccine Market: Breakup by Vaccine Type (in %), 2020
Figure 5: Global: Pneumococcal Vaccine Market: Breakup by Product Type (in %), 2020
Figure 6: Global: Pneumococcal Vaccine Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Pneumococcal Vaccine Market: Breakup by End User (in %), 2020
Figure 8: Global: Pneumococcal Vaccine Market: Breakup by Region (in %), 2020
Figure 9: Global: Pneumococcal Vaccine (Pneumococcal Conjugate Vaccine) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Pneumococcal Vaccine (Pneumococcal Conjugate Vaccine) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Pneumococcal Vaccine (Pneumococcal Polysaccharide Vaccine) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Pneumococcal Vaccine (Pneumococcal Polysaccharide Vaccine) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Pneumococcal Vaccine (Prevnar 13) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Pneumococcal Vaccine (Prevnar 13) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Pneumococcal Vaccine (Synflorix) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Pneumococcal Vaccine (Synflorix) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Pneumococcal Vaccine (Pneumovax 23) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Pneumococcal Vaccine (Pneumovax 23) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Pneumococcal Vaccine (Distribution Partner Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Pneumococcal Vaccine (Distribution Partner Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Pneumococcal Vaccine (Non-Governmental Organizations-NGO) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Pneumococcal Vaccine (Non-Governmental Organizations-NGO) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Pneumococcal Vaccine (Government Authorities) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Pneumococcal Vaccine (Government Authorities) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Pneumococcal Vaccine (Pediatrics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Pneumococcal Vaccine (Pediatrics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Pneumococcal Vaccine (Adults) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Pneumococcal Vaccine (Adults) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: North America: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: North America: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: North America: Pneumococcal Vaccine Market: Breakup by Country (in %), 2020
Figure 32: United States: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: United States: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Canada: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Canada: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Asia-Pacific: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Asia-Pacific: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Asia-Pacific: Pneumococcal Vaccine Market: Breakup by Country (in %), 2020
Figure 39: China: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: China: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Japan: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Japan: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: India: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: India: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: South Korea: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: South Korea: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Australia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Australia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Indonesia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Indonesia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Europe: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Europe: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Europe: Pneumococcal Vaccine Market: Breakup by Country (in %), 2020
Figure 56: Germany: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Germany: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: France: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: France: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: United Kingdom: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: United Kingdom: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Italy: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Italy: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Spain: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Spain: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Russia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Russia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Latin America: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Latin America: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Latin America: Pneumococcal Vaccine Market: Breakup by Country (in %), 2020
Figure 73: Brazil: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Brazil: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Mexico: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Mexico: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Middle East and Africa: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Middle East and Africa: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Middle East and Africa: Pneumococcal Vaccine Market: Breakup by Country (in %), 2020
Figure 82: Global: Pneumococcal Vaccine Industry: SWOT Analysis
Figure 83: Global: Pneumococcal Vaccine Industry: Value Chain Analysis
Figure 84: Global: Pneumococcal Vaccine Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Pneumococcal Vaccine Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Pneumococcal Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2021-2026
Table 3: Global: Pneumococcal Vaccine Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 4: Global: Pneumococcal Vaccine Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Pneumococcal Vaccine Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 6: Global: Pneumococcal Vaccine Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Pneumococcal Vaccine Market: Competitive Structure
Table 8: Global: Pneumococcal Vaccine Market: Key Players
Note: Product cover images may vary from those shown
  • Astellas Pharma Inc.
  • GlaxoSmithKline Plc.
  • Merck & Co. Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt Ltd
  • Walvax Biotechnology Co. Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...